Discontinuation of Clinical Trials. Licensee may terminate this Agreement upon [ * ] advance written notice to Exelixis, if substantially all ongoing Clinical Trials of the Product are ordered or required to be terminated by the FDA or the EMA.
Appears in 4 contracts
Samples: Collaboration and License Agreement (Exelixis, Inc.), Collaboration and License Agreement, Collaboration and License Agreement (Exelixis, Inc.)
